210 related articles for article (PubMed ID: 36085159)
1. Perfluoroalkyl substances (PFASs) as risk factors for breast cancer: a case-control study in Chinese population.
Li X; Song F; Liu X; Shan A; Huang Y; Yang Z; Li H; Yang Q; Yu Y; Zheng H; Cao XC; Chen D; Chen KX; Chen X; Tang NJ
Environ Health; 2022 Sep; 21(1):83. PubMed ID: 36085159
[TBL] [Abstract][Full Text] [Related]
2. Association between exposure to perfluoroalkyl substances and uric acid in Chinese adults.
Yang Z; Men K; Guo J; Liu R; Liu H; Wei J; Zhang J; Liu L; Lin X; Zhang M; Liu Y; Chen Y; Tang NJ
Chemosphere; 2023 Jan; 312(Pt 1):137164. PubMed ID: 36351467
[TBL] [Abstract][Full Text] [Related]
3. Perfluorinated alkylated substances serum concentration and breast cancer risk: Evidence from a nested case-control study in the French E3N cohort.
Mancini FR; Cano-Sancho G; Gambaretti J; Marchand P; Boutron-Ruault MC; Severi G; Arveux P; Antignac JP; Kvaskoff M
Int J Cancer; 2020 Feb; 146(4):917-928. PubMed ID: 31008526
[TBL] [Abstract][Full Text] [Related]
4. Exposure to perfluoroalkyl substances in early pregnancy and the risk of hypertensive disorders of pregnancy: A nested case-control study in Guangxi, China.
Liu B; Wei B; Mo M; Song Y; Tang C; Tang P; Guo X; Tan C; Liu S; Huang D; Qiu X
Chemosphere; 2022 Feb; 288(Pt 1):132468. PubMed ID: 34624345
[TBL] [Abstract][Full Text] [Related]
5. Association of single and multiple prefluoroalkyl substances exposure with preterm birth: Results from a Chinese birth cohort study.
Liao Q; Tang P; Song Y; Liu B; Huang H; Liang J; Lin M; Shao Y; Liu S; Pan D; Huang D; Qiu X
Chemosphere; 2022 Nov; 307(Pt 1):135741. PubMed ID: 35863418
[TBL] [Abstract][Full Text] [Related]
6. Association between perfluoroalkyl and polyfluoroalkyl substances exposure and fetal overgrowth: A prospective birth cohort study conducted in China.
Pan D; Song Y; Liu S; Zeng X; Pang Q; Zhang Y; Wu H; Tan HJJ; Liao Q; Liang J; Huang D; Qiu X
Environ Res; 2023 Sep; 232():116175. PubMed ID: 37257750
[TBL] [Abstract][Full Text] [Related]
7. Exposure to per- and polyfluoroalkyl substances as a risk factor for gestational diabetes mellitus through interference with glucose homeostasis.
Xu C; Zhang L; Zhou Q; Ding J; Yin S; Shang X; Tian Y
Sci Total Environ; 2022 Sep; 838(Pt 4):156561. PubMed ID: 35691348
[TBL] [Abstract][Full Text] [Related]
8. Application of two statistical approaches (Bayesian Kernel Machine Regression and Principal Component Regression) to assess breast cancer risk in association to exposure to mixtures of brominated flame retardants and per- and polyfluorinated alkylated substances in the E3N cohort.
Frenoy P; Perduca V; Cano-Sancho G; Antignac JP; Severi G; Mancini FR
Environ Health; 2022 Feb; 21(1):27. PubMed ID: 35216589
[TBL] [Abstract][Full Text] [Related]
9. Plasma perfluoroalkyl substance exposure and incidence risk of breast cancer: A case-cohort study in the Dongfeng-Tongji cohort.
Feng Y; Bai Y; Lu Y; Chen M; Fu M; Guan X; Cao Q; Yuan F; Jie J; Li M; Meng H; Wang C; Hong S; Zhou Y; Zhang X; He M; Guo H
Environ Pollut; 2022 Aug; 306():119345. PubMed ID: 35472559
[TBL] [Abstract][Full Text] [Related]
10. Maternal plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances during pregnancy and anogenital distance in male infants.
Tian Y; Liang H; Miao M; Yang F; Ji H; Cao W; Liu X; Zhang X; Chen A; Xiao H; Hu H; Yuan W
Hum Reprod; 2019 Jul; 34(7):1356-1368. PubMed ID: 31242507
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk and serum levels of per- and poly-fluoroalkyl substances: a case-control study nested in the California Teachers Study.
Hurley S; Goldberg D; Wang M; Park JS; Petreas M; Bernstein L; Anton-Culver H; Nelson DO; Reynolds P
Environ Health; 2018 Nov; 17(1):83. PubMed ID: 30482205
[TBL] [Abstract][Full Text] [Related]
12. Perfluoroalkyl substances exposure and risk of polycystic ovarian syndrome related infertility in Chinese women.
Wang W; Zhou W; Wu S; Liang F; Li Y; Zhang J; Cui L; Feng Y; Wang Y
Environ Pollut; 2019 Apr; 247():824-831. PubMed ID: 30731307
[TBL] [Abstract][Full Text] [Related]
13. Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Chang VC; Rhee J; Berndt SI; Moore SC; Freedman ND; Jones RR; Silverman DT; Gierach GL; Hofmann JN; Purdue MP
Int J Cancer; 2023 Aug; 153(4):775-782. PubMed ID: 36843273
[TBL] [Abstract][Full Text] [Related]
14. Associations between both legacy and alternative per- and polyfluoroalkyl substances and glucose-homeostasis: The Isomers of C8 health project in China.
Zhang YT; Zeeshan M; Su F; Qian ZM; Dee Geiger S; Edward McMillin S; Wang ZB; Dong PX; Ou YQ; Xiong SM; Shen XB; Zhou PE; Yang BY; Chu C; Li QQ; Zeng XW; Feng WR; Zhou YZ; Dong GH
Environ Int; 2022 Jan; 158():106913. PubMed ID: 34624590
[TBL] [Abstract][Full Text] [Related]
15. Plasma Concentrations of Perfluoroalkyl Substances and Risk of Type 2 Diabetes: A Prospective Investigation among U.S. Women.
Sun Q; Zong G; Valvi D; Nielsen F; Coull B; Grandjean P
Environ Health Perspect; 2018 Mar; 126(3):037001. PubMed ID: 29498927
[TBL] [Abstract][Full Text] [Related]
16. Prenatal exposure to poly/perfluoroalkyl substances and risk for congenital heart disease in offspring.
Li S; Wang C; Yang C; Chen Y; Cheng Q; Liu J; Zhang Y; Jin L; Li Z; Ren A; Wang L
J Hazard Mater; 2024 May; 469():134008. PubMed ID: 38503211
[TBL] [Abstract][Full Text] [Related]
17. Prenatal exposure to perfluoroalkyl substances and thyroid hormone concentrations in cord plasma in a Chinese birth cohort.
Liang H; Wang Z; Miao M; Tian Y; Zhou Y; Wen S; Chen Y; Sun X; Yuan W
Environ Health; 2020 Nov; 19(1):127. PubMed ID: 33243245
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women.
Ren Y; Jin L; Yang F; Liang H; Zhang Z; Du J; Song X; Miao M; Yuan W
Environ Health; 2020 Aug; 19(1):88. PubMed ID: 32807188
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
Mamsen LS; Björvang RD; Mucs D; Vinnars MT; Papadogiannakis N; Lindh CH; Andersen CY; Damdimopoulou P
Environ Int; 2019 Mar; 124():482-492. PubMed ID: 30684806
[TBL] [Abstract][Full Text] [Related]
20. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
